Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis

NCT00447876 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plantar Fasciitis

Interventions

BIOLOGICAL: Botulinum toxin type A
DRUG: Placebo

Sponsor

Ipsen